Oxalatoplatinum
Categorie
Oxalatoplatinum Les marques, Oxalatoplatinum Analogs
Oxalatoplatinum Les marques melange
Oxalatoplatinum Formule chimique
Oxalatoplatinum RX lien
Oxalatoplatinum FDA fiche
Oxalatoplatinum msds (fiche de securite des materiaux)
Oxalatoplatinum Synthese de reference
Oxalatoplatinum Poids moleculaire
Oxalatoplatinum Point de fusion
Oxalatoplatinum H2O Solubilite
Oxalatoplatinum Etat
Oxalatoplatinum LogP
Oxalatoplatinum Formes pharmaceutiques
Oxalatoplatinum Indication
Oxalatoplatinum Pharmacologie
Oxalatoplatinum Absorption
Oxalatoplatinum Toxicite
Oxalatoplatinum Information pour les patients
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
